MedPath

Piroxicam

Generic Name
Piroxicam
Brand Names
Feldene
Drug Type
Small Molecule
Chemical Formula
C15H13N3O4S
CAS Number
36322-90-4
Unique Ingredient Identifier
13T4O6VMAM

Overview

A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily.

Indication

For treatment of osteoarthritis and rheumatoid arthritis.

Associated Conditions

  • Ankylosing Spondylitis (AS)
  • Osteoarthritis (OA)
  • Rheumatoid Arthritis

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/04/24
Not Applicable
Completed
Federal Teaching Hospital Abakaliki
2024/12/11
Phase 3
Not yet recruiting
2024/05/08
Phase 3
Recruiting
Riadh Boukef
2023/02/10
Phase 2
Recruiting
2022/08/05
Phase 4
Completed
Farjad Zafar
2021/11/03
Phase 1
Completed
Nanoform Finland Plc
2019/10/11
Phase 2
Completed
2019/08/20
Early Phase 1
Completed
2019/06/26
Not Applicable
UNKNOWN
2018/11/19
Not Applicable
UNKNOWN

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Vensun Pharmaceuticals, Inc.
42543-114
ORAL
10 mg in 1 1
3/2/2018
Teva Pharmaceuticals USA, Inc.
0093-0756
ORAL
10 mg in 1 1
2/14/2023
PD-Rx Pharmaceuticals, Inc.
72789-210
ORAL
10 mg in 1 1
2/13/2023
DIRECT RX
61919-188
ORAL
20 mg in 1 1
1/21/2020
Zydus Lifesciences Limited
70771-1429
ORAL
10 mg in 1 1
10/4/2023
Unichem Pharmaceuticals (USA), Inc.
29300-256
ORAL
20 mg in 1 1
4/19/2023
Proficient Rx LP
71205-032
ORAL
20 mg in 1 1
12/1/2018
Quality Care Products, LLC
55700-697
ORAL
20 mg in 1 1
11/21/2018
Bryant Ranch Prepack
71335-9622
ORAL
20 mg in 1 1
12/6/2022
Greenstone LLC
59762-0140
ORAL
10 mg in 1 1
2/2/2023

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
ROSIDEN INJECTION 20 mg/ml
SIN06575P
INJECTION
20 mg/ml
9/16/1991
ROSIDEN CAPSULE 20 mg
SIN06131P
CAPSULE
20 mg
5/22/1991
ROSIDEN GEL
SIN05100P
GEL
5 mg/g
10/3/1990
APO-PIROXICAM CAPSULE 10 mg
SIN05491P
CAPSULE
10 mg
2/8/1991
ROXIFEN GEL 500 mg/100 g
SIN10968P
GEL
500 mg/100 g
6/5/1999
APO-PIROXICAM CAPSULE 20 mg
SIN05893P
CAPSULE
20 mg
5/22/1991
BREXIN TABLET 20 mg
SIN07791P
TABLET
20 mg
7/15/1994

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
NU-PIROX CAP 10MG
nu-pharm inc
00865761
Capsule - Oral
10 MG
12/31/1990
RHO-PIROXICAM - CAP 20MG
rhodiapharm inc
02144220
Capsule - Oral
20 MG / CAP
12/31/1995
DOM-PIROXICAM
dominion pharmacal
02239536
Capsule - Oral
20 MG
10/25/1999
ALTI-PIROXICAM-CAP 10MG
altimed pharma inc.
02139952
Capsule - Oral
10 MG / CAP
9/24/1997
PENTA-PIROXICAM CAPSULES
pentapharm ltd.
02232550
Capsule - Oral
20 MG / CAP
N/A
GEN-PIROXICAM - CAP 20MG
genpharm ulc
02171821
Capsule - Oral
20 MG
12/31/1995
TEVA-PIROXICAM
teva canada limited
00695718
Capsule - Oral
10 MG
12/31/1986
FELDENE CAP 20MG
00525618
Capsule - Oral
20 MG / CAP
12/31/1981
APO PIROXICAM CAP 10MG
00642886
Capsule - Oral
10 MG
12/31/1986
FELDENE SUP 10MG
00632708
Suppository - Rectal
10 MG / SUP
12/31/1986

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
SASULEN 5 MG/G GEL
Laboratorios Veris S.A.
58708
GEL
Medicamento Sujeto A Prescripción Médica
Commercialized
PIROXICAM CINFA 20 mg COMPRIMIDOS DISPERSABLES EFG
Laboratorios Cinfa S.A.
62418
COMPRIMIDO DISPERSABLE
Diagnóstico Hospitalario
Commercialized
FELDENE 20 MG/ML SOLUCION INYECTABLE
Pfizer S.L.
58085
SOLUCIÓN INYECTABLE
Diagnóstico Hospitalario
Not Commercialized
IMPRONTAL 5 mg/g CREMA
Meda Pharma S.L.
58198
CREMA
Sin Receta
Not Commercialized
FELDENE 20 MG CAPSULAS DURAS
Pfizer S.L.
55806
CÁPSULA DURA
Diagnóstico Hospitalario
Commercialized
SALVACAM 5mg/g GEL
Laboratorios Salvat S.A.
58986
GEL
Sin Receta
Commercialized
FELDENE FLAS 20 mg LIOFILIZADO ORAL
Pfizer S.L.
60070
LIOFILIZADO ORAL
Diagnóstico Hospitalario
Commercialized
FELDENE 10 MG CAPSULAS DURAS
Pfizer S.L.
55382
CÁPSULA DURA
Diagnóstico Hospitalario
Not Commercialized
FELDEGEL 5 mg/g GEL
Pfizer S.L.
57797
GEL
Medicamento Sujeto A Prescripción Médica
Not Commercialized

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.